LacO-LacI interaction in affinity adsorption of plasmid DNA

Biotechnology and Bioengineering
Gareth M FordeAnthony G Hitchcock

Abstract

Current approaches for purifying plasmids from bacterial production systems exploit the physiochemical properties of nucleic acids in non-specific capture systems. In this study, an affinity system for plasmid DNA (pDNA) purification has been developed utilizing the interaction between the lac operon (lacO) sequence contained in the pDNA and a 64mer synthetic peptide representing the DNA-binding domain of the lac repressor protein, LacI. Two plasmids were evaluated, the native pUC19 and pUC19 with dual lacO3/lacOs operators (pUC19(lacO3/lacOs)), where the lacOs operator is perfectly symmetrical. The DNA-protein affinity interaction was evaluated by surface plasmon resonance using a Biacore system. The affinity capture of DNA in a chromatography system was evaluated using LacI peptide that had been immobilized to Streamline adsorbent. The KD-values for double stranded DNA (dsDNA) fragments containing lacO1 and lacO3 and lacOS and lacO3 were 5.7 +/- 0.3 x 10(-11) M and 4.1 +/- 0.2 x 10(-11) M respectively, which compare favorably with literature reports of 5 x 10(-10)-1 x 10(-9) M for native lacO1 and 1-1.2 x 10(-10) M for lacO1 in a saline buffer. Densitometric analysis of the gel bands from the affinity chromatography run clear...Continue Reading

References

Jan 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·T ItoC R Cantor
Jun 20, 1990·Journal of Molecular Biology·T C BolesN R Cozzarelli
Dec 4, 1987·Cell·S B Straney, D M Crothers
Nov 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·J R SadlerJ L Betz
Aug 3, 1984·Journal of Chromatography·H A Chase
Mar 25, 1981·Journal of Molecular Biology·M Pfahl
Jan 1, 1995·Nature Medicine·R G Crystal
Mar 22, 1996·Journal of Molecular Biology·J MüllerB Müller-Hill
May 20, 1998·Current Opinion in Biotechnology·A Lyddiatt, D A O'Sullivan
Sep 22, 1998·Nucleic Acids Research·T Schluep, C L Cooney
Sep 3, 1999·Nature Biotechnology·J L Fox
Jan 14, 2000·Nature Biotechnology·D Luo, W M Saltzman
Feb 17, 2000·Trends in Biotechnology·A Mountain
Aug 16, 2000·Trends in Biotechnology·G N FerreiraJ M Cabral
Jan 10, 2002·The Journal of Gene Medicine·M M DiogoD M Prazeres
Jul 13, 2002·Biotechnology and Bioengineering·John WoodgateNigel K H Slater
Oct 16, 2002·The Journal of Biological Chemistry·Michael G FriedPonzy Lu
Jan 7, 2003·Biotechnology and Bioengineering·Matteo D CostioliRuth Freitag
Feb 24, 2004·The Journal of Gene Medicine·Joachim StadlerTomas Nyhammar
Jun 5, 2004·Biotechnology Progress·Siddhartha GhoseNigel K H Slater
Mar 12, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Richard A J Darby, Anna V Hine

❮ Previous
Next ❯

Citations

Jun 5, 2007·Nature Protocols·U Loi LaoWilfred Chen
Aug 5, 2008·Trends in Biotechnology·Fani SousaJoão A Queiroz
Sep 4, 2008·The Journal of Gene Medicine·Peter MayrhoferWolfgang Jechlinger
Jun 13, 2015·Journal of the Royal Society, Interface·Edward J HancockAntonis Papachristodoulou
Jan 1, 2010·Biotechnology & Genetic Engineering Reviews·F SousaJ A Queiroz
Dec 22, 2017·Tissue Engineering. Part B, Reviews·Ara Hacobian, David Hercher
May 1, 2007·Biotechnology Journal·Peter TiainenPer-Olof Larsson
May 15, 2007·Biotechnology and Bioengineering·Richard A J DarbyAnna V Hine
Dec 13, 2007·Journal of Molecular Recognition : JMR·Rebecca L Rich, David G Myszka
Jan 23, 2020·Proceedings of the National Academy of Sciences of the United States of America·Robert Shelansky, Hinrich Boeger

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.